Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Johannes F.E. Mann
ResearcherPublications, citations & collaboration network
Johannes F.E. Mann is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 433 works, 48,556 citations, an h-index of 86 and an i10-index of 228.
433
Works
48,556
Citations
86
h-index
228
i10-index
How has Johannes F.E. Mann's publication output changed over time?
ScholarIQpublication output · 2005–2024
Output grew0% over the shown period — from 1 works in 2005 to 1 in 2024.
1
1
1
1
1
1
1
1
1
1
2005200720082013201520162017202020212024
What are the most-cited papers on Johannes F.E. Mann?
ScholarIQmost cited works
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen, Peter Lommer Kristensen, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock, Neil R Poulter, Lasse Steen Ravn, William M. Steinberg, Mette Stockner, Bernard Zinman, Richard M. Bergenstal, John B. Buse
New England Journal of Medicine. 20167,491 CitationsOPEN ACCESS
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter, Glenn M. Chertow, Tom Greene, Fan Fan Hou, Johannes F.E. Mann, John J.V. McMurray, Magnus Lindberg, Peter Rossing, C. David Sjöström, Roberto D. Toto, Anna-Maria Langkilde, David C. Wheeler
New England Journal of Medicine. 20205,353 CitationsOPEN ACCESS
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
Christoph Wanner, Vera Krane, Winfried März, Manfred Olschewski, Johannes F.E. Mann, G. Ruf, Eberhard Ritz
New England Journal of Medicine. 20052,616 CitationsOPEN ACCESS
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort, Ricardo Correa‐Rotter, Brenda R Hemmelgarn, Tazeen H. Jafar, Hiddo J.L. Heerspink, Johannes F.E. Mann, Kunihiro Matsushita, Chi Pang Wen
The Lancet. 20132,225 CitationsOPEN ACCESS
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
Giuseppe Maschio, Daniele Alberti, G. Janin, Francesco Locatelli, Johannes F.E. Mann, M Motolese, Claudio Ponticelli, Eberhard Ritz, P Zucchelli
New England Journal of Medicine. 19961,774 Citations
Related on ScholarIQ
Friedrich-Alexander-Universität Erlangen-Nürnberg
Institution
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Paper
Dapagliflozin in Patients with Chronic Kidney Disease
Paper
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
Paper
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Paper
Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency
Paper